Seagen to highlight data from oncology portfolio and pipeline at the 2023 american society of clinical oncology annual meeting

Bothell, wash.--(business wire)--seagen inc. (nasdaq: sgen) today announced the presentation of 17 abstracts at the upcoming 2023 american society of clinical oncology (asco) annual meeting taking place june 2-6, 2023, in chicago. data will be presented across seagen's portfolio of approved medicines and pipeline agents in a range of cancer types and in earlier lines of therapy. “seagen has worked towards revolutionizing cancer care for 25 years by linking scientific innovation to meaningful im.
SGEN Ratings Summary
SGEN Quant Ranking